181 related articles for article (PubMed ID: 24055523)
1. Acid-degradable core-shell nanoparticles for reversed tamoxifen-resistance in breast cancer by silencing manganese superoxide dismutase (MnSOD).
Cho SK; Pedram A; Levin ER; Kwon YJ
Biomaterials; 2013 Dec; 34(38):10228-37. PubMed ID: 24055523
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer.
Razandi M; Pedram A; Jordan VC; Fuqua S; Levin ER
Oncogene; 2013 Jul; 32(27):3274-85. PubMed ID: 22907432
[TBL] [Abstract][Full Text] [Related]
3. Lysine 68 acetylation directs MnSOD as a tetrameric detoxification complex versus a monomeric tumor promoter.
Zhu Y; Zou X; Dean AE; Brien JO; Gao Y; Tran EL; Park SH; Liu G; Kieffer MB; Jiang H; Stauffer ME; Hart R; Quan S; Satchell KJF; Horikoshi N; Bonini M; Gius D
Nat Commun; 2019 Jun; 10(1):2399. PubMed ID: 31160585
[TBL] [Abstract][Full Text] [Related]
4. Preparation and Characterization of PLGA-PEG-PLGA Nanoparticles Containing Salidroside and Tamoxifen for Breast Cancer Therapy.
Yu X; Sun L; Tan L; Wang M; Ren X; Pi J; Jiang M; Li N
AAPS PharmSciTech; 2020 Jan; 21(3):85. PubMed ID: 31997020
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer.
Guney Eskiler G; Cecener G; Dikmen G; Egeli U; Tunca B
Eur J Pharm Sci; 2018 Jul; 120():73-88. PubMed ID: 29719240
[TBL] [Abstract][Full Text] [Related]
6. Induction of manganese superoxide dismutase (MnSOD) mediates cardioprotective effect of tamoxifen (TAM).
Daosukho C; Ittarat W; Lin SM; Sawyer DB; Kiningham K; Lien YC; St Clair DK
J Mol Cell Cardiol; 2005 Nov; 39(5):792-803. PubMed ID: 16140321
[TBL] [Abstract][Full Text] [Related]
7. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
[TBL] [Abstract][Full Text] [Related]
8. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
9. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
10. High expression of MnSOD promotes survival of circulating breast cancer cells and increases their resistance to doxorubicin.
Fu A; Ma S; Wei N; Tan BX; Tan EY; Luo KQ
Oncotarget; 2016 Aug; 7(31):50239-50257. PubMed ID: 27384484
[TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.
Feng Q; Yu MZ; Wang JC; Hou WJ; Gao LY; Ma XF; Pei XW; Niu YJ; Liu XY; Qiu C; Pang WH; Du LL; Zhang Q
Biomaterials; 2014 Jun; 35(18):5028-38. PubMed ID: 24680191
[TBL] [Abstract][Full Text] [Related]
12. Triptorelin Tethered Multifunctional PAMAM-Histidine-PEG Nanoconstructs Enable Specific Targeting and Efficient Gene Silencing in LHRH Overexpressing Cancer Cells.
Tambe P; Kumar P; Karpe YA; Paknikar KM; Gajbhiye V
ACS Appl Mater Interfaces; 2017 Oct; 9(41):35562-35573. PubMed ID: 28949503
[TBL] [Abstract][Full Text] [Related]
13. MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.
Tengström M; Mannermaa A; Kosma VM; Soini Y; Hirvonen A; Kataja V
Acta Oncol; 2014 Jun; 53(6):769-75. PubMed ID: 24716840
[TBL] [Abstract][Full Text] [Related]
14. Polyamine/DNA polyplexes with acid-degradable polymeric shell as structurally and functionally virus-mimicking nonviral vectors.
Cho SK; Kwon YJ
J Control Release; 2011 Mar; 150(3):287-97. PubMed ID: 21167887
[TBL] [Abstract][Full Text] [Related]
15. Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma.
Kumar AP; Loo SY; Shin SW; Tan TZ; Eng CB; Singh R; Putti TC; Ong CW; Salto-Tellez M; Goh BC; Park JI; Thiery JP; Pervaiz S; Clement MV
Antioxid Redox Signal; 2014 May; 20(15):2326-46. PubMed ID: 23964924
[TBL] [Abstract][Full Text] [Related]
16. ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer Therapy.
Wang J; Chen W; Du W; Zhang H; Ilmer M; Song L; Hu Y; Ma X
Int J Nanomedicine; 2023; 18():2389-2409. PubMed ID: 37192893
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional HER2-antibody conjugated polymeric nanocarrier-based drug delivery system for multi-drug-resistant breast cancer therapy.
Vivek R; Thangam R; NipunBabu V; Rejeeth C; Sivasubramanian S; Gunasekaran P; Muthuchelian K; Kannan S
ACS Appl Mater Interfaces; 2014 May; 6(9):6469-80. PubMed ID: 24780315
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor.
Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN
J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511
[TBL] [Abstract][Full Text] [Related]
19. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
20. Manganese superoxide dismutase mediates anoikis resistance and tumor metastasis in nasopharyngeal carcinoma.
Li S; Mao Y; Zhou T; Luo C; Xie J; Qi W; Yang Z; Ma J; Gao G; Yang X
Oncotarget; 2016 May; 7(22):32408-20. PubMed ID: 27083052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
